Detection of RNA of SARS-CoV strains including SARS-CoV-2 and SARS-like CoV without discriminating between strains. Detection of the virus is responsible for the disease COVID-19 (corona virus disease 2019) and also detection of the new SARS-CoV-2 variant from the UK B1.1.7 (VOC-202012/01), the Delta variant and the variant from South Africa B.1.1.529.
Rapid Test Ag 2019-nCov is a lateral flow test with high sensitivity for the detection of SARS-CoV-2 antigen (nucleocapsid protein) in nasal or nasopharyngeal swab specimens. It helps to rapidly identify infected individuals, enabling prompt clinical decisions and preventing a potential virus outbreak. The test does not require any special instrument and can be used in all types of premises.
Purification of DNA and/or RNA: for DNA and RNA from cell-free media (serum, plasma, body fluids and the supernatant from viral infected cell cultures)
The Rapid Surface Ag 2019-nCov is a rapid test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen (NP) in swabs of common surfaces, such as metal, plastic, glass, paper, and stainless steel. It is the first product for COVID-19 surface testing to utilize this innovative methodology. The Rapid Surface Ag 2019-nCov is a valuable tool for several sectors enabling the companies to monitor and mitigate the spread of COVID-19 in their facilities and maintain a safe operating environment.
The Bio-Shield Surface Ag 2019-nCov is an ELISA test for the measurement of SARS-CoV-2 Nucleocapsid Protein (NP) in swabs of common surfaces. The test is intended for environmental swabbing of larger facilities & spaces and is adequate for up to 48 sample definitions at a time.
0.8687442243099213
Cookies help us deliver our services. By using our services, you agree to our use of cookies.